Clinical Trial: Alterations in Serotonergic Functions in Cocaine Addicts


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Alterations in Serotonergic Functions in Cocaine Addicts - 1

This study has been completed.

Sponsored by:	National Institute on Drug Abuse (NIDA) Department of Veterans Affairs
Information provided by:	National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this study is to evaluate alterations in the serotonergic system in cocaine addicts and attempt to dissociate changes secondary to cocaine use from those associated with premorbid characteristics.

Condition	Treatment or Intervention	Phase
Cocaine-Related Disorders	Drug: M-CPP	Phase I

MedlinePlus related topics: Cocaine Abuse

Study Type: Interventional
Study Design: Treatment, Uncontrolled

Official Title: Alterations in Serotonergic Functions in Cocaine Addicts

Eligibility

Ages Eligible for Study: 25 Years - 50 Years, Genders Eligible for Study: Male

Criteria

Please contact site for information.

Location Information

New York
VA Medical Center, Brooklyn, New York, 11209, United States

Study chairs or principal investigators

Laure Buydens-Branchey, M.D., Principal Investigator, Department of Veterans Affairs

More Information

Study ID Numbers: NIDA-09468-1; R01-09468-1
Record last reviewed: December 2002
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000312
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-16

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services